(Q40642872)

22 September 2017

title

Pharmacokinetics of meropenem in febrile neutropenic patients. Swedish study group (English)

1 reference

22 September 2017

1 reference

1 reference

Nyhlén A

1

1 reference

22 September 2017

Ljungberg B

series ordinal

2

1 reference

22 September 2017

Nilsson-Ehle I

series ordinal

3

1 reference

22 September 2017

publication date

1 November 1997

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

22 September 2017

published in

1 reference

22 September 2017

volume

16

1 reference

22 September 2017

issue

11

1 reference

22 September 2017

page(s)

797-802

1 reference

Pharmacokinetics of meropenem and its metabolite in young and elderly healthy men

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01700408

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700408

Role of pharmacokinetics in the outcome of infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700408

Continuous infusion of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700408

Age dependence of renal function: clearance of iohexol and p-amino hippurate in healthy males

21 January 2018

1 reference

12 December 2020

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Re

1 reference

12 December 2020

Correlation of pharmacokinetic parameters to efficacy of antibiotics: relationships between serum concentrations, MIC values, and bacterial eradication in patients with gram-negative pneumonia.

1 reference

12 December 2020

Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate

1 reference

12 December 2020

Pharmacodynamic effects of meropenem on gram-negative bacteria.

1 reference

12 December 2020

A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients

1 reference

12 December 2020

The postantibiotic effect of meropenem and imipenem on selected bacteria

1 reference

12 December 2020

Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen

1 reference

12 December 2020

Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate

1 reference

12 December 2020

Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males

1 reference

12 December 2020

Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem.

1 reference

12 December 2020

Comparative pharmacokinetics of ceftazidime in young, healthy and elderly, acutely ill males

1 reference

12 December 2020

Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia

1 reference

12 December 2020

In vivo and in vitro study of several pharmacodynamic effects of meropenem

1 reference

12 December 2020

Response of chemostat cultures of Pseudomonas aeruginosa to carbapenems and other beta-lactams.

1 reference

12 December 2020

Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01700408

1 reference

Dimensions Publication ID

22 September 2017

1028049972

0 references

1 reference